Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Recruitment Status: Recruiting"
topic_facet:"Phase: Phase 1, Phase 2"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Recruiting%22&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+1%2C+Phase+2%22&lookfor=%22Study+Type%3A+Interventional%22&type=Subject
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Recruiting%22&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+1%2C+Phase+2%22&lookfor=%22Study+Type%3A+Interventional%22&type=Subject
Search /vufind/Search2/Results?filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Recruiting%22&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+1%2C+Phase+2%22&lookfor=%22Study+Type%3A+Interventional%22&type=Subject
PubPharm (2.908)
1
Study of CD30 CAR for Relapsed/Refractory CD30+ HL and CD30+ NHL : Phase Ib/II Study of the Administration of T Lymphocytes Expressing the CD30 Chimeric Antigen Receptor (CAR) for Relapsed/Refractory CD30+ Hodgkin's Lymphoma and CD30+ Non-Hodgkin's Lymphoma
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
2
Administration of Autologous CAR-T CD19 Antigen With Inducible Safety Switch in Patients With Relapsed/Refractory ALL : Administration of Autologous CAR-T Cells Targeting the CD19 Antigen and Containing the Inducible caspase9 Safety Switch in Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
3
Ph I/II Trial of Systemic VSV-IFNβ-NIS in Combination With Checkpoint Inhibitor Therapy in Patients With Select Solid Tumors : Phase 1-2 Trial of Systemically Administered VSV-IFNβ-NIS in Combination With Checkpoint Inhibitor Therapy in Patients With Selected Solid Tumors
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
4
Lu-177-DOTATATE (Lutathera) in Combination With Olaparib in Inoperable Gastroenteropancreatico Neuroendocrine Tumors (GEP-NET) : Phase I/II Study of Lu-177-DOTATATE (Lutathera) in Combination With Olaparib in Inoperable Gastroenteropancreatico Neuroendocrine Tumors (GEP-NET)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
5
Venetoclax and Azacitidine for the Treatment of High-Risk Recurrent or Refractory Myelodysplastic Syndrome : Phase I/II of Venetoclax in Combination With Azacitidine in Treatment Naïve and Relapse Refractory High Risk MDS Individuals"
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
6
Natural Killer-cell Therapy for Acute Myeloid Leukemia : Infusion of ex Vivo-generated Allogeneic Natural Killer Cells in Combination With Subcutaneous IL-2 in Patients With Acute Myeloid Leukemia: a Phase I/IIa Study
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
7
Tucatinib Plus Trastuzumab and Oxaliplatin-based Chemotherapy or Pembrolizumab-containing Combinations for HER2+ Gastrointestinal Cancers : A Phase 1b/2 Dose Escalation and Expansion Study of Tucatinib in Combination With Trastuzumab and Oxaliplatin-based Chemotherapy or Pembrolizumab-containing Combinations for HER2+ Gastrointestinal Cancers
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
8
Venetoclax and Azacitidine for the Treatment of Relapsed or Refractory High-Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia : A Phase I/II Study of Venetoclax in Combination With Azacitidine in Relapsed/Refractory High-Risk Myelodysplastic Syndrome (MDS) or Chronic Myelomonocytic Leukemia (CMML)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
9
Study BT8009-100 in Subjects With Nectin-4 Expressing Advanced Malignancies : Phase I/II Study of the Safety, Pharmacokinetics, and Preliminary Clinical Activity of BT8009 in Patients With Nectin-4 Expressing Advanced Malignancies
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
10
M9241 in Combination With Docetaxel in Adults With Metastatic Castration Sensitive and Castration Resistant Prostate Cancer : A Phase I/II Study of M9241 With Docetaxel and Abiraterone in Adults With Metastatic Castration Sensitive and M9241 With Docetaxel in Castration Resistant Prostate Cancer
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[291]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Thema: Recruitment Status: Recruiting
Filter aufheben
Thema: Phase: Phase 1, Phase 2
Medienart
2.908
Aufsätze
2.908
E-Artikel
2.908
E-Ressourcen
Zeitschriftentitel
2.908
ClinicalTrials.gov
Thema
2.908
610
Phase: Phase 1, Phase 2
Recruitment Status: Recruiting
2.908
Study Type: Interventional
400
Neoplasms
203
Lymphoma
199
Carcinoma
186
Leukemia
146
Carcinoma, Non-Small-Cell Lung
138
Lung Neoplasms
130
Breast Neoplasms
89
Leukemia, Myeloid
87
Multiple Myeloma
85
Leukemia, Myeloid, Acute
82
Colorectal Neoplasms
82
Lymphoma, Non-Hodgkin
82
Neoplasms, Plasma Cell
81
Prostatic Neoplasms
78
Adenocarcinoma
77
Syndrome
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
1.370
2024
1.127
2023
306
2022
105
2021
Erscheinungsjahr(e)
Von:
Bis:
Sprache
2.908
Englisch
Haven't found what you're looking for?
Wird geladen...